Alexza Pharmaceuticals, Inc.and Grupo Ferrer Internacional, S.A.,announced that the European Commission has granted marketing authorization for Adasuve (Staccato loxapine). In...
The FDA Psychopharmacologic Advisory Committee voted 9-8 to recommend Adasuve (inhaled loxapine) from Alexza Pharma, to treat agitation associated with...
Alexza Pharmaceuticals, Inc. announced that they have entered into an exclusive U.S. license and supply agreement with Teva Pharmaceutical Industries...
Alexza Pharmaceuticals announced that it has received a Complete Response Letter(CRL) from the FDA regarding its New Drug Application (NDA)...
Alexza Pharmaceuticals, Inc.and Grupo Ferrer Internacional, S.A. announced that they have entered into a definitive agreement under which Ferrer Pharma...
Alexza Pharmaceuticals, Inc. and Grupo Ferrer Internacional, S.A., have announced that the Committee for Medicinal Products for Human Use (CHMP)...